Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19.

Alejo, Jennifer L; Mitchell, Jonathan; Chang, Amy; Chiang, Teresa P Y; Massie, Allan B; Segev, Dorry L; Makary, Martin A

Alejo, Jennifer L; Mitchell, Jonathan; Chang, Amy; Chiang, Teresa P Y; Massie, Allan B; Segev, Dorry L; Makary, Martin A.

Alejo JL; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Mitchell J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Chang A; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Chiang TPY; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Massie AB; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Segev DL; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Makary MA; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

JAMA ; 327(11): 1085-1087, 2022 03 15.

Article in English | MEDLINE | ID: covidwho-1763143

Subject(s)

Antibodies, Viral/blood; COVID-19/blood; SARS-CoV-2/immunology; Adult; Female; Humans; Male; Middle Aged; Time Factors; United States; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: JAMA Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google